<html><head>          <title></title><meta content="width=device-width, initial-scale=1.0" name="viewport">     <style type="text/css">         /* Basic Resets */         body { width: 100% !important; -webkit-text-size-adjust: 100%; -ms-text-size-adjust: 100%; margin: 0; padding: 0; background-color: #f1f5f9; }         table { border-collapse: collapse !important; mso-table-lspace: 0pt; mso-table-rspace: 0pt; }         img { outline: none; text-decoration: none; -ms-interpolation-mode: bicubic; border: 0; }         body, table, td, p, a, li { font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif; }                  /* Layout Helper Classes */         .container { width: 600px; background-color: #ffffff; border-radius: 12px; overflow: hidden; box-shadow: 0 10px 30px rgba(0,0,0,0.08); }         .content-padding { padding: 40px 45px !important; }                  /* Updated Headings - Title Case */         .section-header { font-size: 28px; font-weight: 800; color: #00afe6; margin: 0 0 10px 0; letter-spacing: -0.5px; }         .body-text { color: #4a5568; font-size: 16px; line-height: 1.75; margin: 0 0 20px 0; }         .sub-heading { color: #1a202c; font-size: 22px; font-weight: bold; margin: 0 0 15px 0; letter-spacing: -0.3px; }         .link-style { color: #00afe6; text-decoration: none; font-weight: bold; }         .divider { height: 1px; background-color: #edf2f7; margin: 30px 0; }                  /* Highlighting Colors */         .cas-blue { color: #00afe6 !important; }         .cann-pink { color: #e91e63 !important; }                  @media only screen and (max-width: 620px) {             .container { width: 100% !important; border-radius: 0 !important; }             .content-padding { padding: 30px 20px !important; }             .responsive-image { width: 100% !important; height: auto !important; }             .stack { width: 100% !important; display: block !important; }         }     </style>      <meta content="text/html;charset=UTF-8" http-equiv="Content-Type"></head><body style=" -ms-text-size-adjust: 100%; -webkit-text-size-adjust: 100%;width: 100% !important;font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif; background-color: #f1f5f9; padding: 0;margin: 0; background-color: #f1f5f9; font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;">     <table bgcolor="#f1f5f9" border="0" cellpadding="0" cellspacing="0" style="border-collapse: collapse !important; mso-table-lspace: 0pt; mso-table-rspace: 0pt;font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;" width="100%">         <tbody>             <tr>                 <td align="center" style="font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;padding: 30px 0;">                     <table border="0" cellpadding="0" cellspacing="0" class="container" style=";width: 600px; background-color: #ffffff; border-radius: 12px; overflow: hidden; box-shadow: 0 10px 30px rgba(0,0,0,0.08);border-collapse: collapse !important; mso-table-lspace: 0pt;font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif; mso-table-rspace: 0pt;background-color: #ffffff; border-radius: 12px; overflow: hidden;" width="600">                         <!-- Header -->                         <tbody>                             <tr>                                 <td align="center" style="font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;padding: 35px 30px 25px 30px; border-bottom: 4px solid #00afe6;">                                     <table border="0" cellpadding="0" cellspacing="0" style="border-collapse: collapse !important; mso-table-lspace: 0pt; mso-table-rspace: 0pt;font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;" width="100%">                                         <tbody>                                             <tr>                                                 <td align="center" style="font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;">                                                     <img alt="Canadian Amyloidosis Society Logo" class src="https://stratus.campaign-image.com/images/1767774519236_1_zc_v1_1553680000000116018.jpeg" style=" border: 0; -ms-interpolation-mode: bicubic;outline: none; text-decoration: none;display: block; width: 220px; margin: 0 auto;" width="220">                                                 </td>                                             </tr>                                             <tr>                                                 <td align="center" style="font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;padding-top: 10px;">                                                     <p style="font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;margin: 0; font-size: 12px; color: #718096; font-weight: bold; letter-spacing: 1px; text-transform: uppercase;">January 2026 Edition</p>                                                 </td>                                             </tr>                                         </tbody>                                     </table>                                     <div style="margin-top: 20px;">                                         <p style="font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;margin: 0; font-size: 20px; color: #2d3748; font-weight: bold; text-align: center;">Canadian Amyloidosis Society Newsletter</p>                                     </div>                                 </td>                             </tr>                             <!-- Main Content Start -->                             <tr>                                 <td class="content-padding" style="font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;padding: 40px 45px !important;;">                                     <h1 class="section-header" style="font-size: 28px; font-weight: 800; color: #00afe6; margin: 0 0 10px 0; letter-spacing: -0.5px;">News and Events</h1>                                                                          <!-- Summit Image Section -->                                     <div style="margin-bottom: 12px;">                                         <!-- Top Hero Image -->                                         <img alt="Summit Main Event" class src="https://stratus.campaign-image.com/images/2d226423_9ba2_4a2b_b87c_05bf881cd89a_zc_v3_1553680000000116018.jpg" style=" border: 0; -ms-interpolation-mode: bicubic;outline: none; text-decoration: none;width: 100%; height: auto; border-radius: 8px; display: block; object-fit: cover;" width="510">                                     </div>                                                                          <!-- Side by Side Images -->                                     <table border="0" cellpadding="0" cellspacing="0" style="border-collapse: collapse !important; mso-table-lspace: 0pt; mso-table-rspace: 0pt;font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;" width="100%">                                         <tbody><tr>                                             <td class="stack" style="font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;" valign="top" width="49%">                                                 <img alt="Summit Presentation" class src="https://stratus.campaign-image.com/images/d33be37a_54c0_47a5_891b_f018d610f554_zc_v3_1553680000000116018.jpg" style=" border: 0; -ms-interpolation-mode: bicubic;outline: none; text-decoration: none;width: 100%; height: 160px; border-radius: 8px; object-fit: cover; display: block;" width="250">                                             </td>                                             <td class="stack" style="font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;font-size: 1px; line-height: 1px;" width="2%">&nbsp;</td>                                             <td class="stack" style="font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;" valign="top" width="49%">                                                 <img alt="Summit Attendees" class src="https://stratus.campaign-image.com/images/6110ba86_43ba_413c_9bf7_00e4a1ce8c19_zc_v3_1553680000000116018.jpg" style=" border: 0; -ms-interpolation-mode: bicubic;outline: none; text-decoration: none;width: 100%; height: 160px; border-radius: 8px; object-fit: cover; display: block;" width="250">                                             </td>                                         </tr>                                     </tbody></table>                                      <!-- Canadian Amyloidosis Summit Text -->                                     <div style="margin-top: 35px;">                                         <h2 class="sub-heading" style="color: #1a202c; font-size: 22px; font-weight: bold; margin: 0 0 15px 0; letter-spacing: -0.3px;">Canadian Amyloidosis Summit 2025</h2>                                         <p class="body-text" style="font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;color: #4a5568; font-size: 16px; line-height: 1.75; margin: 0 0 20px 0;;">In partnership with <strong class="cas-blue" style="color: #00afe6 !important;">Transthyretin Amyloidosis Canada (TAC)</strong>, the Canadian Amyloidosis Summit was held in Toronto the weekend of <strong class="cas-blue" style="color: #00afe6 !important;">November 1-2, 2025</strong>, with over 120 people attending. This hybrid event featured parallel sessions for both healthcare providers and patients/families, with <strong class="cas-blue" style="color: #00afe6 !important;">CME accreditation</strong> for healthcare provider sessions.</p>                                         <p class="body-text" style="font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;color: #4a5568; font-size: 16px; line-height: 1.75; margin: 0 0 20px 0;;">The Summit featured interesting presentations and panel discussions from many national and internationally recognized leaders from the amyloidosis community. The CAS also held its first <strong class="cas-blue" style="color: #00afe6 !important;">Annual General Meeting (AGM)</strong> at the Summit. Planning for the <strong class="cas-blue" style="color: #00afe6 !important;">2026 Canadian Amyloidosis Summit</strong> next fall is already underway. Stay tuned for future updates and hope you can join us!</p>                                     </div>                                      <!-- Journal Club Callout -->                                     <table border="0" cellpadding="0" cellspacing="0" style="border-collapse: collapse !important; mso-table-lspace: 0pt;font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif; mso-table-rspace: 0pt;background-color: #edfaff; border-radius: 8px; margin: 35px 0;" width="100%">                                         <tbody>                                             <tr>                                                 <td style="font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;padding: 30px;">                                                     <h2 style="color: #00afe6; font-size: 22px; font-weight: bold; margin: 0 0 12px 0;">CAS Journal Club</h2>                                                     <p style="font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;color: #4a5568; font-size: 15px; line-height: 1.75; margin-bottom: 15px;">CAS Journal Club continues with quarterly virtual presentations featuring interesting amyloidosis cases from across Canada. The November 2025 CAS journal club included great case discussions presented by <strong class="cas-blue" style="color: #00afe6 !important;">Dr. Janine Mazengarb</strong> from the University of British Columbia and <strong class="cas-blue" style="color: #00afe6 !important;">Dr. Rajin Choudhury</strong> from the University of Calgary.</p>                                                     <p style="font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;margin: 0; color: #2d3748; font-size: 15px;"><strong>Next Session:</strong> <span class="cas-blue" style="color: #00afe6 !important;">February 26th at 5-6 PM EST</span></p>                                                     <p style="font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;margin: 5px 0 15px 0; font-size: 14px; color: #718096;">Presenters to be announced. All CAS members are welcome to join; the Zoom link will be sent by e-mail to all members in advance.</p>                                                     <a href="https://amyloid.ca/journal-club" style="font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;color: #00afe6; text-decoration: none; font-weight: bold; font-size: 15px;">More details at amyloid.ca/journal-club &rarr;</a>                                                 </td>                                             </tr>                                         </tbody>                                     </table>                                      <div class="divider" style="height: 1px; background-color: #edf2f7; margin: 30px 0;"></div>                                      <!-- CANN Section -->                                     <div style="text-align: center;">                                         <img alt="CANN Logo" src="https://stratus.campaign-image.com/images/cann_rgb_dark_theme_1756219144378_dhmf_rl6_zc_v5_1553680000000116018.png" style=" border: 0; -ms-interpolation-mode: bicubic;outline: none; text-decoration: none;height: 90px; width: 250px; margin-bottom: 20px;" width="250">                                     </div>                                     <h2 class="sub-heading cann-pink" style="color: #1a202c; font-size: 22px; font-weight: bold; margin: 0 0 15px 0; letter-spacing: -0.3px;color: #e91e63 !important;;">Canadian Amyloidosis Nursing Network</h2>                                     <p class="body-text" style="font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;color: #4a5568; font-size: 16px; line-height: 1.75; margin: 0 0 20px 0;;">CANN is pleased to invite members to the following upcoming events:</p>                                     <table border="0" cellpadding="0" cellspacing="0" style="border-collapse: collapse !important; mso-table-lspace: 0pt;font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif; mso-table-rspace: 0pt;margin-bottom: 20px;" width="100%">                                         <tbody>                                             <tr>                                                 <td style="font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;padding-top: 5px;" valign="top" width="30"><span class="cann-pink" style="color: #e91e63 !important;font-size: 20px;">&bull;</span></td>                                                 <td style="font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;">                                                     <p style="font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;margin: 0; font-weight: bold; color: #2d3748; font-size: 16px;">CANN Townhall: <span class="cann-pink" style="color: #e91e63 !important;">January 22, 2026</span></p>                                                     <p style="font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;color: #4a5568; font-size: 15px; line-height: 1.75; margin-top: 5px;">Join us for a <strong class="cann-pink" style="color: #e91e63 !important;">virtual ideation workshop</strong>. This professionally facilitated round table discussion is designed for members to connect and share ideas. <a class="cann-pink" href="https://amyloid.ca/cann-resources" style=";color: #e91e63 !important;font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;font-weight: bold; text-decoration: none;">Registration is OPEN!</a></p>                                                 </td>                                             </tr>                                             <tr>                                                 <td style="font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;padding-top: 5px;" valign="top" width="30"><span class="cann-pink" style="color: #e91e63 !important;font-size: 20px;">&bull;</span></td>                                                 <td style="font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;">                                                     <p style="font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;margin: 0; font-weight: bold; color: #2d3748; font-size: 16px;">CANN Educational Series: <span class="cann-pink" style="color: #e91e63 !important;">February 18, 2026</span></p>                                                     <p style="font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;color: #4a5568; font-size: 15px; line-height: 1.75; margin-top: 5px;">Join us to <strong class="cann-pink" style="color: #e91e63 !important;">deepen understanding</strong> surrounding the role of <strong class="cann-pink" style="color: #e91e63 !important;">PYP scans</strong> in the management of amyloidosis. Click the link above to learn more.</p>                                                 </td>                                             </tr>                                         </tbody>                                     </table>                                 </td>                             </tr>                             <!-- Global Updates Header -->                             <tr>                                 <td align="center" style="font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;padding: 25px 45px; background-color: #2d3748;">                                     <h2 style="margin: 0; color: #ffffff; font-size: 20px; font-weight: bold; letter-spacing: 0.5px;">Updates from the World of Amyloidosis</h2>                                 </td>                             </tr>                             <!-- Global News Content -->                             <tr>                                 <td class="content-padding" style="font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;padding: 40px 45px !important;;">                                     <h3 style="color: #2d3748; font-size: 20px; font-weight: bold; margin: 0 0 10px 0;">Health Canada Notice of Compliance for Vutrisiran</h3>                                     <p class="body-text" style="font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;color: #4a5568; font-size: 16px; line-height: 1.75; margin: 0 0 20px 0;;">In December 2025, Health Canada provided the Notice of Compliance for <strong class="cas-blue" style="color: #00afe6 !important;">vutrisiran (Amvuttra, Alnylam Pharmaceuticals)</strong> for the treatment of wild-type or hereditary transthyretin-mediated amyloidosis cardiomyopathy. The approval broadens the indication for vutrisiran, from its existing indication for the treatment <strong class="cas-blue" style="color: #00afe6 !important;">Stage 1 or stage 2 polyneuropathy</strong> in patients with hereditary transthyretin-mediated amyloidosis.</p>                                                                          <!-- Clinical Trial Alert -->                                     <table border="0" cellpadding="0" cellspacing="0" style="border-collapse: collapse !important; mso-table-lspace: 0pt;font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif; mso-table-rspace: 0pt;background-color: #fff5f5; border: 1px solid #feb2b2; border-radius: 8px; margin: 30px 0;" width="100%">                                         <tbody>                                             <tr>                                                 <td style="font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;padding: 25px;">                                                     <h3 style="color: #c53030; font-size: 19px; font-weight: bold; margin: 0 0 10px 0;">MAGNITUDE Clinical Trial Enrollment Placed on Hold</h3>                                                     <p style="font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;color: #742a2a; font-size: 15px; line-height: 1.75;">On <strong class="cas-blue" style="color: #00afe6 !important;">October 27, 2025</strong>, Intellia Therapeutics paused enrollment in its <strong class="cas-blue" style="color: #00afe6 !important;">MAGNITUDE clinical trial</strong> after one participant experienced severe elevations in liver transaminases, meeting the study&rsquo;s pre-defined safety criteria. The participant was hospitalized and sadly passed away from complications of acute liver failure. Subsequently, the <strong class="cas-blue" style="color: #00afe6 !important;">U.S. FDA</strong> placed the trial on clinical hold.</p>                                                     <p style="font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;font-size: 14px; margin: 0; font-style: italic; color: #a94442;">The MAGNITUDE (NCT06128629) trial is evaluating <strong class="cas-blue" style="color: #00afe6 !important;">nexiguran ziclumeran (nex-z)</strong> for the treatment of ATTR cardiomyopathy using <strong class="cas-blue" style="color: #00afe6 !important;">CRISPR/Cas9 technology</strong>.</p>                                                 </td>                                             </tr>                                         </tbody>                                     </table>                                      <h3 style="color: #2d3748; font-size: 20px; font-weight: bold; margin: 0 0 10px 0;">International Symposium on Amyloidosis</h3>                                     <p class="body-text" style="font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;color: #4a5568; font-size: 16px; line-height: 1.75; margin: 0 0 20px 0;;">The International Society of Amyloidosis (ISA) will be holding its international symposium <strong class="cas-blue" style="color: #00afe6 !important;">November 15-18, 2026</strong>, in beautiful <strong class="cas-blue" style="color: #00afe6 !important;">Montevideo, Uruguay</strong>. For more details and to register for this exciting event please visit the ISA website: <a href="https://isaamyloidosis.org" style="font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;color: #00afe6; font-weight: bold; text-decoration: none;">isaamyloidosis.org</a></p>                                                                          <div class="divider" style="height: 1px; background-color: #edf2f7; margin: 30px 0;"></div>                                     <!-- Closing -->                                     <p class="body-text" style=";color: #4a5568; font-size: 16px; line-height: 1.75; margin: 0 0 20px 0;font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;margin-bottom: 5px;">Thank you for being part of the movement.</p>                                     <p style="font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;margin: 0; color: #1a202c; font-size: 16px; font-weight: bold;">                                         With gratitude,<br>                                         <span class="cas-blue" style="color: #00afe6 !important;">The CAS Team</span><br>                                         <span style="font-weight: normal; color: #718096; font-size: 14px;">Canadian Amyloidosis Society</span>                                     </p>                                 </td>                             </tr>                             <!-- Footer -->                             <tr>                                 <td align="center" style="font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;padding: 50px 45px; background-color: rgb(26, 32, 44);">                                     <p style="font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;color: rgb(255, 255, 255); margin: 0px; font-weight: bold; font-size: 17px; letter-spacing: 0.5px;">Canadian Amyloidosis Society</p>                                     <p style="font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;margin: 10px 0px;"><a href="https://amyloid.ca" style="font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;color: #00afe6; font-weight: bold; text-decoration: none; font-size: 15px;">www.amyloid.ca</a></p>                                     <p style="font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;color: rgb(255, 255, 255); margin: 30px 0px 0px; font-size: 12px; opacity: 0.5; line-height: 1.6;">                                         Helping improve the lives of Canadians affected by amyloidosis.<br>                                         &copy; 2026 Canadian Amyloidosis Society. All rights reserved.                                     </p>                                     <p style="font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;margin: 20px 0px 0px; font-size: 12px; color: #ffffff;">                                         <a href="https://amyloid.ca/" style="font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;color: #ffffff; opacity: 0.7;"><u>Privacy Policy</u></a> |                                           <a href="http://#$[LI:UNSUBSCRIBE]$" style="font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;color: #ffffff; opacity: 0.7;"><u>Unsubscribe</u></a>                                     </p>                                 </td>                             </tr>                         </tbody>                     </table>                 </td>             </tr>         </tbody>     </table> </body></html>